Skip to main content
. 2016 Feb 10;11(2):e0148657. doi: 10.1371/journal.pone.0148657

Fig 4. SB204741 restricts motion of pSRC.

Fig 4

(A) SB204741 reduces tubulin and perinuclear SRC motility, both of which are increased in mutant microvascular endothelial cells. Eularian analysis of fluorescently labeled tubulin and SRC in endothelial cells shows elevated motility in vehicle treated mutant cells, as well as a significant decrease in motility in mutants cells treated with SB204741. Values are expressed as mean ± standard error. n = 5–10, *p<0.05 compared to WT, #p<0.05 compared to vehicle treated.